Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Lorlatinib is a third-generation ALK/ROS1 tyrosine kinase inhibitor, primarily indicated for the treatment of ALK-positive or ROS1-positive advanced non-small cell lung cancer (NSC···【more】
Article source：Captain MedicineRelease date：2026-01-27Recommended：220
Lorlatinib is a third-generation targeted therapy indicated for ALK-positive metastatic non-small cell lung cancer (NSCLC), primarily used in patients who have developed resistance···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：177
Concurrent use of this medicine with any of the following medications is generally not recommended, but may be necessary in certain circumstances. If both medications are prescribe···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：224
While certain medications should not be used together at all, in other cases, it may be necessary to use two different drugs simultaneously even if an interaction might occur.What ···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：192
While exerting the intended therapeutic effects, a medication may also induce certain adverse reactions. Although not all side effects will occur, medical attention may be required···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：172
In addition to the intended effects, medications may cause some adverse reactions. Although not all of these side effects may occur, medical attention may be required if they do ap···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：183
Lorlatinib is an antineoplastic (anticancer) medication. It interferes with the growth of cancer cells, which are eventually eliminated by the body. This medicine is available only···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：175
Lorlatinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring specific types of anaplastic lymphoma kinase (ALK) gene abnormali···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：184
Lorlatinib is a targeted therapy indicated for the treatment of ALK-positive non-small cell lung cancer (NSCLC). Its dietary restrictions primarily aim to avoid foods that may inte···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：223
Lorlatinib is a targeted therapy indicated for the treatment of specific ALK or ROS1-positive advanced non-small cell lung cancer (NSCLC). It must be administered strictly in accor···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：271
The common adverse reactions of Lorlatinib include metabolic abnormalities, central nervous system (CNS) symptoms, edema, weight gain, and peripheral neuropathy. Most of these reac···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：198
The side effects of lorlatinib involve multiple systems, including the central nervous system, endocrine system, digestive system, respiratory system, neuromusculoskeletal system, ···【more】
Article source：Captain MedicineRelease date：2026-01-26Recommended：202
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
